Androgen receptor (AR), a steroid receptor linked to transcription factor involved in cell proliferation and apoptosis, was seen in 34% of the TNBC patients in our study, which correlates with other experiences, of which one author reported 2,000 invasive breast cancers, where in AR was positive in only 32% of the TNBCs. This evidence concerns the gene AR and invasive breast carcinoma.